AllDocs -> cancers

21 Urinary Bladder Cancer Cancer of the urinary bladder is the fifth most common cancer in the United States. Each year, approximately 38,000 men and 15,000 women are diagnosed with bladder cancer . This is the fourth most common type of cancer in men and the eighth most common in women. Like almost any malignancy, bladder cancer is a multifactorial disease with both an environmental and genetic component. The most important known risk factor for bladder cancer is cigarette smoking; cigarette smokers develop bladder cancer two to three times more often than nonsmokers (Silverman et al., in press). Risk increases with amount smoked (number of packs per day), with moderate to heavy smokers experiencing two to five times the risk of nonsmokers. Quitting smoking is associated with a 30% to 60% decrease in risk. Smoking is estimated to be responsible for about 48% of the bladder ...

Expression of b 1 -integrins and N-cadherin in bladder cancer and melanoma cell lines *. Piotr Laidler 1 , Dorota Gil 1 , Anna Pituch-Noworolska 2 , Dorota Cio³czyk 1 , Dorota Ksi¹¿ek 1 , Ma³gorzata Przyby³o 3 and Anna Lityñska 3 1 Institute of Medical Biochemistry, Collegium Medicum, Jagiellonian University, Kraków, 2 Department of Clinical Immunology, Polish-American Children’s Hospital, Collegium Medicum, Jagiellonian University, Kraków, 3 Institute of Zoology, Department of Animal Physiology, Jagiellonian University, Kraków, Poland Received: 29 May, 2000; revised: 20 October, 2000; accepted: 14 November, 2000 Key words: cadherins, integrins, cell lines, cancer , cytofluorimetry Changes in the expression ...

Special Communication The International Bladder Cancer Bank: proposal for a new study concept Peter J. Goebell a,b, *, Susan Groshen c , Bernd J. Schmitz-Dräger d , Richard Sylvester e , Manolis Kogevinas f , Núria Malats f , Guido Sauter g , H. Barton Grossman h , Fred Waldman i , Richard J. Cote a a Departments of Pathology and Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA b Department of Urology, University of Essen, Essen, Germany c Department of Preventive Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA d ...

A215- Urinary bladder cancer tissues (formalin fixed) For research use only Specifications: • No. of cases: 45 • Tissue type: Urinary bladder cancer tissues • No. of spots: 2 spots from each cancer case (90 spots) 4 non-neoplastic spots (4 spots) •Total spots: 94 • Corresponding normal tissues with cancers: Yes • Diameter: 1. 0 mm Documents : • Product specification: layout, summary of tissue spots • H&E stained images • Detailed pathological information Layout: 1 2 3 4 5 6 7 8 9 10 11 A B C D E F G H I : Urothelial carcinoma : Urothelial carcinoma in situ : Adenocarcinoma + other pathology : Squamous carcinoma : Non-neoplastic Page 2 ...

bladder cancer 1146 BLADDER CANCER DIAGNOSTIC AND TREATMENT PATHWAY Gold Standard Timescale Emergency Presentation A&E AP Key Referral to GP Non urgent Emergency Information Flow Patient Flow AP Audited ...

BLADDER CANCER - All Sections BLADDER CANCER What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells often travel to other parts of the body where they begin to grow and replace normal tissue. This process, called metastasis, occurs as the cancer cells get into the bloodstream ...

What You Need To Know About Bladder Cancer NATIONAL INSTITUTES OF HEALTH National Cancer Institute ™ What You Need To Know About Index Page 2 This booklet is about bladder cancer . The Cancer Information Service can help you learn more about this disease. The staff can talk with you in English or Spanish. The number is 1–800–4– CANCER (1–800–422–6237). The number for deaf and hard of hearing callers with TTY equipment is 1–800–332–8615. The call is free. Este folleto es acerca del cáncer de la vejiga. Llame al Servicio de Información sobre el Cáncer para saber más sobre esta enfermedad. Este servicio tiene personal que habla español. El número a llamar es el 1–800–4– CANCER (1–800–422–6237). Personas con dificultades de audición ...

© 20 06 B JU I N TER N A TI O N A L | 9 7, 2 27 –2 3 1 | doi:10.1111/j.1464-410X.2006.05896.x 22 7 LYMPHADENECTOMY FOR BLADDER CANCER STEIN et al. Lymphadenectomy for invasive bladder cancer : I. historical perspective and contemporary rationale JOHN P. STEIN, MARCUS L. QUEK and DONALD G. SKINNER Department of Urology, University of Southern California Keck School of Medicine, USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA Accepted for publication 19 August 2005 KEYWORDS bladder cancer , cystectomy, lymphadenectomy, lymph-node metastases INTRODUCTION In the USA bladder cancer is the fourth most common cancer in men and the eighth most common in women, with TCC comprising nearly 90% of all primary bladder tumours. In 2004, it was estimated that 60 250 new ...

Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity MAL Moneef 1 , BT Sherwood 1,2 , KJ Bowman 1 , RC Kockelbergh 2 , RP Symonds 3 , WP Steward 3 , JK Mellon 2 and GDD Jones * ,1 1 Department of Cancer Studies and Molecular Medicine, Hodgkin Building, University of Leicester, Lancaster Road, PO Box 138, Leicester LE1 9HN, UK; 2 University Division of Urology, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK; 3 University Department of Cancer Studies and Molecular Medicine, Osborne Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK In the UK, the two main treatments of invasive bladder cancer are radiotherapy or cystectomy. However, B50% of patients ...